Thus, it can be appreciated that urinary mindin can function as a biomarker of podocyte injury in diabetic nephropathy; however, its general usage will be limited until further investigations can determine its efficacy in this and other glomerulopathies. This evidence concerns the gene SPON2 and diabetic kidney disease.